Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Abatacept in treatment-resistant sarcoidosis
DRKS00011660Phase 2Completed
- Sponsor
- Universitätsklinikum Freiburg
- Start
- Oct 2017
- Modality
- Fc-Fusion Proteins → Carrier/Scaffold Proteins → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of abatacept in sarcoidosis, sponsored by Universitätsklinikum Freiburg. Started Oct 2017; status: completed.
02
Drugs
abatacept
03
Conditions
sarcoidosis
Beyond the preview
Go deeper on DRKS00011660.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00011660.